ALIGN TECHNOLOGY, INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies- 売上
- $4.0bn
- 時価総額
- $12.8bn
株価 $173.41 · 100株 2万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $3.9bn | $4.0bn | $4.0bn |
| 成長率 | — | 3.5% | 0.9% |
| 総利益 | $2.7bn | $2.8bn | $2.7bn |
| 総利益率 | 70.1% | 70.0% | 67.2% |
| 販管費 | $1.7bn | $1.8bn | $1.8bn |
| 販管費率 | 44.1% | 44.1% | 43.5% |
| 営利 | $643m | $608m | $546m |
| 営利率 | 16.7% | 15.2% | 13.5% |
| 純利益 | $445m | $421m | $410m |
| PBR | 3.5 | 3.3 | 3.2 |
| PSR | 3.3 | 3.2 | 3.2 |
| PGPR | 4.7 | 4.6 | 4.7 |
| PER | 29 | 30 | 31 |
| ネットキャッシュ | $937m | $1.0bn | $1.1bn |
| EV/EBITDA | 15.0 | 15.6 | 14.9 |
| Rule of 40 | — | 19% | 14% |
| セールス効率 | — | 154% | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
